Delivery Order SPE2DB20D2104-SPE2DB25FMQCS

Award Date 5/5/25
Potential Completion Date 5/6/25
Potential Value $4.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML. The contract has a firm fixed price, a ceiling value of $5,952.07, and a period of performance through May 1, 2025. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of NOVOLOG 100 UNIT/ML VIAL 10ML. The contract has a ceiling value of $4,006.50 and a period of performance through April 16, 2025. This delivery order is placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,005.10 contract is for the supply of 4,568,093,505 units of NOVOLOG 100 UNIT/ML VIAL 10ML, a diabetes treatment medication. The contract has a period of performance through May 1, 2025. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product. The contract has a ceiling value of $2,724.00 and an ultimate completion date of July 23, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract through a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,327.81, is for the procurement of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product. The contract has an ultimate completion date of March 10, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a prescription medication, with a ceiling value of $17,732.62 and a performance period through April 16, 2025. The contract is not set-aside and was competed openly. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,272.07, is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of January 28, 2025 and is not designated with a set-aside requirement, indicating open competition....
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a diabetes treatment medication, with a ceiling value of $15,765.12 and a performance period ending on May 1, 2025. The contract is not set aside and was awarded on April 30, 2025. Amerisourcebergen Drug Corp is the prime contractor and holds a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,260.76, is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a medical product used for healthcare purposes. The contract has an ultimate completion date of January 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product. The contract has a ceiling value of $28,179.83 and a period of performance through March 26, 2024. Amerisourcebergen Drug Corp is the prime contractor for this award, which is a child contract under a larger indefinite delivery contract...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMQCS
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML. The contract has a ceiling value of $4,363.88 and a period of performance through May 6, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation, indicating open competition. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This contract positions Amerisourcebergen as a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 8/4/25, 9:53 AM